Skip to content
Search

Latest Stories

Pharmacy contractors to receive earlier advance payments from November

Following an agreement between the Pharmaceutical Services Negotiating Committee (PSNC) and the Department of Health and Social Care (DHSC), all community pharmacy contractors will be able to receive earlier advance payments from November.

Contractors, who make their monthly FP34C submissions through the Manage Your Service (MYS) portal by the 5th of the month, will receive payments about 20 days earlier than the current timetable.


The agreement, aimed at benefiting all contractors, came as part of discussions on the Pharmacy Earlier Payment Scheme (PEPS), which DHSC had decided to end following the collapse of Greensill Capital.

The option to receive earlier payments is available for all prescriptions dispensed after October 2021.

The negotiator has also advised all contractors to start using the MYS portal to make their declarations, as the FP34C submission document will not be available after March 2022.

Meanwhile, the final PEPS payments will be paid on October 1, 2021 and from November 1, a 12-month transition period will begin, allowing contractors to shift to the new earlier advance payment timetable.

PSNC chief executive Simon Dukes said: “The option for all community pharmacy contractors to bring forward the timing of their advance payments is a long overdue and very welcome development that will benefit all pharmacy businesses.

“The move to using MYS will mean changes for some contractors so we have made sure that they have the time to do this: this is all part of integrating us, including digitally, better with the NHS, and in the long term going digital should make processes more streamlined.

“This should significantly ease cashflow pressures on contractors currently using the PEPS.”

To help contractors in understanding and using the new system, the PSNC is also planning to hold a webinar.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less